The Skinkandy share price closed at A$2.80 on Friday, yet the fresh full year numbers tell a far tighter story than that calm finish suggests. The headline is margin pressure. Trailing net profit sits at A$0.641 million on A$90.512 million of revenue, which leaves the business with a slim 0.7% net margin and far less earnings cushion than a year ago.
For a retailer often treated as a growth story, the expectation gap is clear. Same store sales growth of 9.6% is doing its job; however, the profit squeeze is now the real battleground for Skinkandy.
Is Skinkandy at A$2.80 a mispriced growth story, given a 0.7% trailing net margin and a modelled fair value of A$6.99, or a value trap in disguise? Compare the current market price to the underlying cash flow assumptions in our valuation analysis for Skinkandy
Prefer clean charts over slogging through dense tables and raw earnings figures? Get a full visual read on Skinkandy, including how its recent profit squeeze appears across valuation, earnings history and key metrics, in the company report for Skinkandy.
Skinkandy still offers a growth leaning story built around customers walking through the door. Revenue of A$90.512 million compares with A$71.779 million in the prior year, which backs the idea that the brand and store footprint continue to attract spending. Same store sales growth of 9.6% adds another layer, since that speaks to existing locations pulling more weight rather than just new openings. For a niche retailer, that combination of higher reported sales and healthy in store momentum supports a view that demand for the piercing led proposition is holding up.
The bearish angle focuses squarely on earnings quality. Net income excluding extra items moved from A$8.132 million to A$0.641 million and the trailing net margin now sits at 0.7% rather than 11.3%. That is a sharp compression for a retailer with store level fixed costs. Basic EPS tells the same story, weakening from A$0.086052 per share to A$0.006667 per share. Even with solid same store sales growth, these figures highlight how little room Skinkandy currently has for error if costs rise further or trading conditions soften.
Access the analyst playbook to see where Skinkandy might break out of this tight earnings squeeze. Reveal what the street is quietly modeling for revenue, margins and EPS over the next few years in the analyst estimates for Skinkandy
If Skinkandy’s thin 0.7% net margin and large gap between A$2.80 and the modelled fair value have caught your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and spot a potential entry that fits your plan. Once you are set on a position, keep your decisions clear by running everything through the Portfolio Command Center, which focuses you on key alerts instead of day to day noise. For longer term conviction, compare your thinking with thousands of investors inside the Community and see how others are reacting to new data on Skinkandy. By spotting emerging catalysts and risks early, you give yourself a better shot at staying ahead of the wider market.
Fresh ideas move first. By the time every investor is talking about a breakout story, the easy entry points can be gone. Scan these under the radar groups while it matters and look for opportunities early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com